ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc (ARWR)

19,49
-0,30
(-1,52%)
Beim Schlusskurs: 06 Januar 10:00PM
19,50
0,01
( 0,05% )
Nach Börsenschluss: 10:04PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
19,50
Gebot
19,50
Fragen
19,88
Volumen
1.460.554
19,155 Tagesbereich 20,30
17,05 52-Wochen-Bereich 39,83
Marktkapitalisierung
Handelsende
19,79
Handelsbeginn
19,79
Letzte Trade
1
@
19.51
Letzter Handelszeitpunkt
22:04:52
Finanzvolumen
US$ 29.036.411
VWAP
19,8804
Durchschnittliches Volumen (3 Mio.)
1.468.268
Ausgegebene Aktien
124.434.442
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,05
Gewinn pro Aktie (EPS)
-4,82
Erlöse
3,55M
Nettogewinn
-599,49M

Über Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfol... Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Coml Physical, Biologcl Resh
Hauptsitz
Camden, Delaware, USA
Gegründet
2016
Arrowhead Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARWR. The last closing price for Arrowhead Pharmaceuticals was US$19,79. Over the last year, Arrowhead Pharmaceuticals shares have traded in a share price range of US$ 17,05 to US$ 39,83.

Arrowhead Pharmaceuticals currently has 124.434.442 shares in issue. The market capitalisation of Arrowhead Pharmaceuticals is US$2,46 billion. Arrowhead Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.05.

Option-Flow Arrowhead Pharmaceuticals (ARWR)

Gesamtfluss

Bullisch

Nettoprämie

8k

Calls / Puts

100,00%

Käuf. / Verkä.

0,00%

OTM / ITM

100,00%

Sweeps

0,00%

ARWR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.643.393425238618.8620.5418.25116424119.20586439CS
4-4.17-17.617237008923.6724.2518.25137191020.56661931CS
121.075.8057514921318.4327.3418.03146826821.45553001CS
26-6.49-24.971142747225.9930.4117.05123439622.29127538CS
52-15.6-44.444444444435.139.8317.05123155525.57085838CS
156-40.78-67.650962176560.2862.2517.05105347430.68994252CS
260-41.41-67.985552454460.9193.6617.05105538640.06953103CS

ARWR - Frequently Asked Questions (FAQ)

What is the current Arrowhead Pharmaceuticals share price?
The current share price of Arrowhead Pharmaceuticals is US$ 19,50
How many Arrowhead Pharmaceuticals shares are in issue?
Arrowhead Pharmaceuticals has 124.434.442 shares in issue
What is the market cap of Arrowhead Pharmaceuticals?
The market capitalisation of Arrowhead Pharmaceuticals is USD 2,46B
What is the 1 year trading range for Arrowhead Pharmaceuticals share price?
Arrowhead Pharmaceuticals has traded in the range of US$ 17,05 to US$ 39,83 during the past year
What is the PE ratio of Arrowhead Pharmaceuticals?
The price to earnings ratio of Arrowhead Pharmaceuticals is -4,05
What is the cash to sales ratio of Arrowhead Pharmaceuticals?
The cash to sales ratio of Arrowhead Pharmaceuticals is 683,86
What is the reporting currency for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Arrowhead Pharmaceuticals?
The latest annual turnover of Arrowhead Pharmaceuticals is USD 3,55M
What is the latest annual profit for Arrowhead Pharmaceuticals?
The latest annual profit of Arrowhead Pharmaceuticals is USD -599,49M
What is the registered address of Arrowhead Pharmaceuticals?
The registered address for Arrowhead Pharmaceuticals is 2140 SOUTH DUPONT HIGHWAY, KENT, CAMDEN, DELAWARE, 19934
What is the Arrowhead Pharmaceuticals website address?
The website address for Arrowhead Pharmaceuticals is www.arrowheadpharma.com
Which industry sector does Arrowhead Pharmaceuticals operate in?
Arrowhead Pharmaceuticals operates in the COML PHYSICAL, BIOLOGCL RESH sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MSAIMultiSensor AI Holdings Inc
US$ 2,9701
(47,03%)
1,11M
RGFReal Good Food Company Inc
US$ 1,62
(23,66%)
483,47k
NARIInari Medical Inc
US$ 78,4507
(20,58%)
1,18M
SVMHSRIVARU Holding Ltd
US$ 0,0544
(17,62%)
14,02M
CDTConduit Pharmaceuticals Inc
US$ 0,082
(14,85%)
7,71M
SLRNACELYRIN Inc
US$ 3,03
(-13,18%)
157,06k
BOXLBoxlight Corporation
US$ 1,46
(-11,25%)
768,43k
WATTEnergous Corporation
US$ 1,10
(-9,09%)
184,41k
BDRXBiodexa Pharmaceuticals PLC
US$ 4,0728
(-8,48%)
113
PIIIP3 Partners Inc
US$ 0,2299
(-7,56%)
2,2k
XTIAXTI Aerospace Inc
US$ 0,0906
(9,67%)
88,95M
SVMHSRIVARU Holding Ltd
US$ 0,0544
(17,62%)
14,02M
CDTConduit Pharmaceuticals Inc
US$ 0,082
(14,85%)
7,71M
RIMEAlgorhythm Holdings Inc
US$ 0,1545
(6,77%)
6,09M
UPWKUpwork Inc
US$ 16,20
(0,00%)
2,96M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen